Published in Antimicrob Agents Chemother on June 01, 1993
Integron-mediated rifampin resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1999) 2.38
Ribosylation by mycobacterial strains as a new mechanism of rifampin inactivation. Antimicrob Agents Chemother (1995) 1.49
Ribosylative inactivation of rifampin by Mycobacterium smegmatis is a principal contributor to its low susceptibility to this antibiotic. Antimicrob Agents Chemother (1997) 1.29
Molecular basis of rifampin resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother (1999) 1.24
Sequence and analysis of the rpoB gene of Mycobacterium smegmatis. Antimicrob Agents Chemother (1995) 1.22
Monooxygenase-like sequence of a Rhodococcus equi gene conferring increased resistance to rifampin by inactivating this antibiotic. Antimicrob Agents Chemother (1997) 1.16
Contribution of rpoB2 RNA polymerase beta subunit gene to rifampin resistance in Nocardia species. Antimicrob Agents Chemother (2006) 0.92
Characterization of a rifampin-inactivating glycosyltransferase from a screen of environmental actinomycetes. Antimicrob Agents Chemother (2012) 0.89
Inactivation of the macrolide antibiotics erythromycin, midecamycin, and rokitamycin by pathogenic Nocardia species. Antimicrob Agents Chemother (1994) 0.84
ADP-ribosylation as an intermediate step in inactivation of rifampin by a mycobacterial gene. Antimicrob Agents Chemother (1999) 0.81
Pathogenic Nocardia, Rhodococcus, and related organisms are highly susceptible to imidazole antifungals. Antimicrob Agents Chemother (2003) 0.80
The Structure of the Antibiotic Deactivating, N-hydroxylating Rifampicin Monooxygenase. J Biol Chem (2016) 0.75
Arr-cb, a rifampin resistance determinant found active or cryptic in Clostridium bolteae. Antimicrob Agents Chemother (2017) 0.75
Aminoglycoside antibiotic-inactivating enzymes in actinomycetes similar to those present in clinical isolates of antibiotic-resistant bacteria. Proc Natl Acad Sci U S A (1973) 5.20
Actions of the rifamycins. Bacteriol Rev (1971) 3.66
Rifampicin: a new orally active rifamycin. Chemotherapy (1966) 2.64
Mutation to rifampicin resistance at the beginning of the RNA polymerase beta subunit gene in Escherichia coli. Mol Gen Genet (1984) 2.38
In vivo activities of newer rifamycin analogs against Mycobacterium avium infection. Antimicrob Agents Chemother (1991) 1.55
Microbial glycosylation of erythromycin A. Antimicrob Agents Chemother (1989) 1.27
Alteration of ribosomes and RNA polymerase in drug-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother (1985) 1.01
Synthesis and biological activity of some derivatives of rifamycin P. J Med Chem (1990) 1.01
Cloning of nocardioform DNA conferring the ability to inactivate rifampicin. FEMS Microbiol Lett (1991) 1.01
Biosynthetic studies on saframycin A, a quinone antitumor antibiotic produced by Streptomyces lavendulae. J Biol Chem (1985) 1.00
Molecular structure and conformation of rifamycin S, a potent inhibitor of DNA-dependent RNA polymerase. J Antibiot (Tokyo) (1992) 0.99
Correlation of structure and activity in ansamycins: molecular structure of cyclized rifamycin SV. J Antibiot (Tokyo) (1984) 0.92
Rifamycins: an insight into biological activity based on structural investigations. J Mol Biol (1974) 0.89
In-vitro activity of new carbapenem antibiotics: comparative studies with meropenem, L-627 and imipenem against pathogenic Nocardia spp. J Antimicrob Chemother (1992) 0.88
In vitro susceptibility of Nocardia spp. to a new fluoroquinolone, tosufloxacin (T-3262). Antimicrob Agents Chemother (1989) 0.88
Inactivation of kanamycin A by phosphorylation in pathogenic Nocardia. Microbiol Immunol (1991) 0.85
[Coordination of the 13C-NMR. spectrum of rifamycin S on the basis of selective uncoupling of protons]. Helv Chim Acta (1973) 0.81
Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor. Nature (1986) 4.97
Interaction of colicins with bacterial cells. I. Studies with radioactive colicins. J Bacteriol (1966) 4.25
PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc Natl Acad Sci U S A (2001) 3.32
Myeloscopy, with special reference to blood flow changes in the cauda equina during Lasègue's test. Int Orthop (1981) 2.82
Growth site localization of Rho1 small GTP-binding protein and its involvement in bud formation in Saccharomyces cerevisiae. J Cell Biol (1994) 2.74
Characterization of In53, a class 1 plasmid- and composite transposon-located integron of Escherichia coli which carries an unusual array of gene cassettes. J Bacteriol (2001) 2.68
Encoding of Ca2+ signals by differential expression of IP3 receptor subtypes. EMBO J (1999) 2.63
Rapid focus reduction neutralization test of influenza A and B viruses in microtiter system. J Clin Microbiol (1990) 2.60
The codon CUG is read as serine in an asporogenic yeast Candida cylindracea. Nature (1989) 2.57
Atomic model of a pyrimidine dimer excision repair enzyme complexed with a DNA substrate: structural basis for damaged DNA recognition. Cell (1995) 2.36
Glutamic acid 204 is the terminal proton release group at the extracellular surface of bacteriorhodopsin. J Biol Chem (1995) 2.36
CENP-H, a constitutive centromere component, is required for centromere targeting of CENP-C in vertebrate cells. EMBO J (2001) 2.32
Primary structure of porcine cardiac muscarinic acetylcholine receptor deduced from the cDNA sequence. FEBS Lett (1986) 2.03
Binding site of cerulenin in fatty acid synthetase. J Biochem (1989) 1.98
Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection. Hepatology (1994) 1.96
Pregnancy and childbirth outcomes among adolescent mothers: a World Health Organization multicountry study. BJOG (2014) 1.93
Molecular cloning and functional characterization of a novel receptor-activated TRP Ca2+ channel from mouse brain. J Biol Chem (1998) 1.90
Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells. J Virol (2000) 1.89
BCAP: the tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation. Immunity (2000) 1.86
Elements of neural adhesion molecules and a yeast vacuolar protein sorting receptor are present in a novel mammalian low density lipoprotein receptor family member. J Biol Chem (1996) 1.80
Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease. Blood (2000) 1.78
Structure and assembly of turnip crinkle virus. I. X-ray crystallographic structure analysis at 3.2 A resolution. J Mol Biol (1986) 1.76
Microbial Conversion of alpha-Ionone, alpha-Methylionone, and alpha-Isomethylionone. Appl Environ Microbiol (1988) 1.72
Prevalence of mitochondrial gene mutations among hearing impaired patients. J Med Genet (2000) 1.71
Rhizoxin, a macrocyclic lactone antibiotic, as a new antitumor agent against human and murine tumor cells and their vincristine-resistant sublines. Cancer Res (1986) 1.68
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Four cases of postrenal renal failure induced by renal stone associated with rotavirus infection. Clin Nephrol (2010) 1.65
Conversion of bacteriorhodopsin into a chloride ion pump. Science (1995) 1.65
Reduced elimination of IgG antibodies by engineering the variable region. Protein Eng Des Sel (2010) 1.64
Nocardial infections in Japan from 1992 to 2001, including the first report of infection by Nocardia transvalensis. Eur J Epidemiol (2004) 1.64
Normal myelination of anatomic nerve fiber bundles: MR analysis. AJNR Am J Neuroradiol (1998) 1.60
Mitochondrial ATP-sensitive potassium channels attenuate matrix Ca(2+) overload during simulated ischemia and reperfusion: possible mechanism of cardioprotection. Circ Res (2001) 1.59
Second-look arthroscopy after meniscal repair. Review of 132 menisci repaired by an arthroscopic inside-out technique. J Bone Joint Surg Br (1995) 1.54
Invasive Aspergillus stomatitis in patients with acute leukemia: report of 12 cases. Clin Infect Dis (2001) 1.54
Maternal complications and perinatal mortality: findings of the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG (2014) 1.54
Energy coupling in an ion pump. The reprotonation switch of bacteriorhodopsin. J Mol Biol (1994) 1.49
Ribosylation by mycobacterial strains as a new mechanism of rifampin inactivation. Antimicrob Agents Chemother (1995) 1.49
Human diabetes associated with a mutation in the tyrosine kinase domain of the insulin receptor. Science (1989) 1.46
Delayed post-prandial lipid metabolism in subjects with intra-abdominal visceral fat accumulation. Eur J Clin Invest (1999) 1.44
Fourier transform infrared study of the N intermediate of bacteriorhodopsin. Biochemistry (1991) 1.43
Protein changes associated with reprotonation of the Schiff base in the photocycle of Asp96-->Asn bacteriorhodopsin. The MN intermediate with unprotonated Schiff base but N-like protein structure. J Biol Chem (1992) 1.42
The ability of anti-carbonic anhydrase II antibody to distinguish autoimmune cholangitis from primary biliary cirrhosis in Japanese patients. J Gastroenterol (1999) 1.40
Release of coronavirus E protein in membrane vesicles from virus-infected cells and E protein-expressing cells. Virology (1999) 1.39
Monoclonal anti-Fc epsilon receptor antibodies with different specificities and studies on the expression of Fc epsilon receptors on human B and T cells. J Immunol (1986) 1.39
Molecular cloning and characterization of yeast rho GDP dissociation inhibitor. J Biol Chem (1994) 1.39
An autopsy case of diffuse panbronchiolitis associated with lung cancer. Intern Med (2000) 1.39
Survey on subjective symptoms in office workers using visual display terminals. Fukushima J Med Sci (1988) 1.38
Sodium- and calcium-dependent spike potentials in the secretory neuron soma of the X-organ of the crayfish. J Gen Physiol (1971) 1.38
Diffusion anisotropy and diffusivity of white matter tracts within the temporal stem in Alzheimer disease: evaluation of the "tract of interest" by diffusion tensor tractography. AJNR Am J Neuroradiol (2006) 1.35
Regulation of the phospholipase C-gamma2 pathway in B cells. Immunol Rev (2000) 1.34
Articular cartilage lesions in ankles with lateral ligament injury. An arthroscopic study. Am J Sports Med (1993) 1.33
Carbon dioxide absorbents containing potassium hydroxide produce much larger concentrations of compound A from sevoflurane in clinical practice. Anesth Analg (2000) 1.32
Blockade of interleukin-6 receptor suppresses reactive astrogliosis and ameliorates functional recovery in experimental spinal cord injury. J Neurosci Res (2004) 1.31
Ustiloxins, antimitotic cyclic peptides from false smut balls on rice panicles caused by Ustilaginoidea virens. J Antibiot (Tokyo) (1994) 1.31
Changes in the incidence and prevalence of rheumatoid arthritis in Kamitonda, Wakayama, Japan, 1965-1996. Ann Rheum Dis (1999) 1.30
A novel Go-mediated phototransduction cascade in scallop visual cells. J Biol Chem (1997) 1.29
Primary invasive micropapillary carcinoma of the colon. Histopathology (2005) 1.28
Characteristics of cyclosporine induction of increased prostaglandin levels from human peripheral blood monocytes. Transplantation (1984) 1.28
Chromogenicity of Streptomyces. Appl Microbiol (1972) 1.27
Relationship of proton release at the extracellular surface to deprotonation of the schiff base in the bacteriorhodopsin photocycle. Biophys J (1995) 1.26
Light-driven chloride ion transport by halorhodopsin from Natronobacterium pharaonis. 1. The photochemical cycle. Biochemistry (1995) 1.26
Selective coupling with K+ currents of muscarinic acetylcholine receptor subtypes in NG108-15 cells. Nature (1988) 1.26
Molecular characterization of the E gene of dengue virus type 1 isolated in Guangdong province, China, in 2006. Epidemiol Infect (2008) 1.25
Rhizoxin binding to tubulin at the maytansine-binding site. Biochim Biophys Acta (1987) 1.24
Homogeneous quantitative assay of hepatitis C virus RNA by polymerase chain reaction in the presence of a fluorescent intercalater. Anal Biochem (1995) 1.24
Genotypic subtyping of hepatitis C virus. J Gastroenterol Hepatol (1993) 1.23
Characterization of a neu/c-erbB-2 protein-specific activating factor. Proc Natl Acad Sci U S A (1991) 1.21
Different rifampicin inactivation mechanisms in Nocardia and related taxa. Microbiol Immunol (1996) 1.20
Expression of vascular endothelial growth factor (VEGF) family members in breast cancer. Jpn J Cancer Res (1999) 1.20
Isomeric composition of retinal chromophore in dark-adapted bacteriorhodopsin. J Biochem (1977) 1.19
Mini-plasmin found in the epithelial cells of bronchioles triggers infection by broad-spectrum influenza A viruses and Sendai virus. Eur J Biochem (2001) 1.18
Penetration of the duodenum by an ingested needle with migration to the pancreas: report of a case. Surg Today (2001) 1.18
Genetic analysis of Histoplasma capsulatum strains isolated from clinical specimens in thailand by a PCR-based random amplified polymorphic DNA method. J Clin Microbiol (1998) 1.16
"Lupinosis"-like lesions in mice caused by ustiloxin, produced by Ustilaginoieda virens: a morphological study. Nat Toxins (1994) 1.16
Antifungal, antimitotic and anti-HIV-1 agents from the roots of Wikstroemia indica. Planta Med (2000) 1.15
Heterogeneity of influenza B virus strains in one epidemic season differentiated by monoclonal antibodies and nucleotide sequences. J Clin Microbiol (2000) 1.14
Formation of 9-cis- and 11-cis-retinal pigments from bacteriorhodopsin by irradiating purple membrane in acid. Biochemistry (1980) 1.14
Interaction of ustiloxin A with bovine brain tubulin. Biochem Pharmacol (1994) 1.14
Involvement of cannabinoid CB2 receptor in alcohol preference in mice and alcoholism in humans. Pharmacogenomics J (2006) 1.14
Water and peptide backbone structure in the active center of bovine rhodopsin. Biochemistry (1997) 1.14
Application of subtype-specific monoclonal antibodies for rapid detection and identification of influenza A and B viruses. J Clin Microbiol (1998) 1.13
Human mannan-binding lectin inhibits the infection of influenza A virus without complement. Immunology (1999) 1.13
Phagocytosis of Candida albicans by rabbit alveolar macrophages and guinea pig neutrophils. Sabouraudia (1977) 1.12
Molecular characterization of new clinical isolates of Candida albicans and C. dubliniensis in Japan: analysis reveals a new genotype of C. albicans with group I intron. J Clin Microbiol (2001) 1.12
Mechanisms of photoreceptor cell death in cancer-associated retinopathy. Invest Ophthalmol Vis Sci (2001) 1.11
Serotyping of Cryptococcus neoformans strains isolated from clinical specimens in Thailand and their susceptibility to various antifungal agents. Eur J Epidemiol (1997) 1.10
Membrane topology of coronavirus E protein. Virology (2001) 1.10
Isolation and structure of an antimitotic cyclic peptide, ustiloxin F: chemical interrelation with a homologous peptide, ustiloxin B. J Antibiot (Tokyo) (1998) 1.09
Endogenous Nocardia asteroides endophthalmitis in a patient with systemic lupus erythematosus. Br J Ophthalmol (1990) 1.09
In-vitro activity of flomoxef, a new oxacephem group antibiotic, against Nocardia in comparison with other cephalosporins. J Antimicrob Chemother (1989) 1.09
Phosphorylative inactivation of rifampicin by Nocardia otitidiscaviarum. J Antimicrob Chemother (1994) 1.09